← Back to Search

Behavioral Intervention

ADEPT Intervention for Vaccine Hesitancy (ADEPT Trial)

N/A
Recruiting
Led By Lavanya Vasudevan, PhD, MPH
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months post birth
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to increase parental confidence in childhood vaccinations by providing expectant parents with accurate information during pregnancy.

Who is the study for?
This trial is for expectant parents with a single pregnancy, no prior live births, and no known fetal issues. They must be in the early third trimester and getting prenatal care at a participating practice. Those at risk for preterm birth cannot join.
What is being tested?
The study tests if giving factual vaccine information to expectant parents during pregnancy can increase their confidence in childhood vaccines and ensure their child gets vaccinated on time.
What are the potential side effects?
Since this intervention involves providing information rather than a medical treatment, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months post birth
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months post birth for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Proportion of children receiving timely vaccinations
Secondary study objectives
Change in Vaccine Hesitancy

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ADEPTExperimental Treatment1 Intervention
Individuals receiving prenatal care at a practice that was randomized to deliver the ADEPT intervention.
Group II: Standard of CareActive Control1 Intervention
Individuals receiving prenatal care at a practice that was randomized to deliver the standard of care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ADEPT
2023
N/A
~160

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,708 Previous Clinical Trials
2,606,714 Total Patients Enrolled
1 Trials studying Vaccine Refusal
1,200 Patients Enrolled for Vaccine Refusal
Lavanya Vasudevan, PhD, MPHPrincipal InvestigatorEmory University

Media Library

ADEPT (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05795855 — N/A
Vaccine Refusal Research Study Groups: ADEPT, Standard of Care
Vaccine Refusal Clinical Trial 2023: ADEPT Highlights & Side Effects. Trial Name: NCT05795855 — N/A
ADEPT (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05795855 — N/A
~337 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top